Intraperitoneal chemotherapy for malignant peritoneal mesothelioma
- 30 June 1991
- journal article
- case report
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (6) , 732-734
- https://doi.org/10.1016/0277-5379(91)90176-e
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Peritoneal Malignant Mesothelioma versus Serous Papillary AdenocarcinomaThe American Journal of Surgical Pathology, 1989
- Amosite mesothelioma in a cohort of asbestos workers.Scandinavian Journal of Work, Environment & Health, 1989
- Escalating dose regimen of intraperitoneal mitoxantrone: Phase I study—clinical and pharmacokinetic evaluationEuropean Journal of Cancer and Clinical Oncology, 1988
- Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985.Journal of Clinical Oncology, 1988
- Long-term survival in peritoneal mesothelioma the role of radiotherapy and combined modality treatmentCancer, 1987
- Intraperitoneal antineoplastic agents for tumors principally confined to the peritoneal cavityCancer Treatment Reviews, 1986
- EARLY PERITONEAL MESOTHELIOMA: A TREATABLE MALIGNANCYThe Lancet, 1985
- Clinical pharmacology of intraperitoneal cisplatinGynecologic Oncology, 1985
- Non-asbestos-related malignant mesothelioma. A reviewCancer, 1984
- Peritoneal mesothelioma: natural history and response to chemotherapy.Journal of Clinical Oncology, 1983